Bioinformaticians sought to improve Finch’s accuracy and reliability.
FutureHouse, a nonprofit backed by Eric Schmidt, has introduced Finch, an AI tool designed to assist biological research. Finch analyses biology data and research papers, generating figures and insights much like a first-year graduate student might.
FutureHouse aims to automate aspects of scientific discovery, though no significant breakthroughs have yet been reported.
Despite optimism from tech leaders, many scientists doubt AI’s current value in guiding complex research.
Finch, while promising, can still make errors, prompting FutureHouse to recruit bioinformaticians and computational biologists to help refine the tool. The platform remains in closed beta as development continues.
The biotech AI market is expanding, yet previous ventures have suffered clinical trial setbacks. Finch represents a cautious step forward, balancing potential with careful human oversight. Interested experts are invited to participate in its ongoing evaluation.
Would you like to learn more about AI, tech and digital diplomacy? If so, ask our Diplo chatbot!